Saario SM, Savinainen JR, Laitinen JT, Jarvinen T, Niemi R (2004) Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 67: 1381-1387
Sabbadini RA, Betto R, Teresi A, Fachechi-Cassano G, Salviati G (1992) The effects of sphingosine on sarcoplasmic reticulum membrane calcium release. J Biol Chem 267: 15475-15484
Sacerdote P, Massi P, Panerai AE, Parolaro D (2000) In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J Neuroimmunol 109: 155-163
Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C (1999) Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Eur J Neurosci 11: 691-699
Saito T, Ochiai H (1993) Evidence for a glycolipid anchor of gp64, a putative cell-cell adhesion protein of Polysphondylium pallidum. Eur J Biochem 218: 623-628
Salio C, Cottone E, Conrath M, Franzoni MF (2002) CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers. J Chem Neuroanat 24: 153-162
Salio C, Doly S, Fischer J, Franzoni MF, Conrath M (2002) Neuronal and astrocytic localization of the cannabinoid receptor-1 in the dorsal horn of the rat spinal cord. Neurosci Lett 329: 13-16
Salio C, Fischer J, Franzoni MF, Conrath M (2002) Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. Neuroscience 110: 755-764
Salio C, Fischer J, Franzoni MF, Mackie K, Kaneko T, Conrath M (2001) CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn. Neuroreport 12: 3689-3692
Salomon Y (1990) Melanocortin receptors: targets for control by extracellular calcium. Mol Cell Endocrinol 70: 139-145
Salzet M (2000) Invertebrate molecular neuroimmune processes. Brain Res Brain Res Rev 34: 69-79
Salzet M (2001) Neuroimmunology of opioids from invertebrates to human. Neuroendocrinol Lett 22: 467-474
Salzet M, Breton C, Bisogno T, Di Marzo V (2000) Comparative biology of the endocannabinoid system possible role in the immune response. Eur J Biochem 267: 4917-4927
Salzet M, Salzet-Raveillon B, Cocquerelle C, Verger-Bocquet M, Pryor SC, Rialas CM, Laurent V, Stefano GB (1997) Leech immunocytes contain proopiomelanocortin: nitric oxide mediates hemolymph proopiomelanocortin processing. J Immunol 159: 5400-5411
Salzet M, Stefano GB (2002) The endocannabinoid system in invertebrates. Prostaglandins Leukot Essent Fatty Acids 66: 353-361
Sampei K, Goto S, Alkayed NJ, Crain BJ, Korach KS, Traystman RJ, Demas GE, Nelson RJ, Hurn PD (2000) Stroke in estrogen receptor-alpha-deficient mice. Stroke 31: 738-743; discussion 744
Sampson HW, Bowers DE, Cannon MS, Piscopo I (1982) Intracellular calcium localization in stimulated and non-stimulated extraorbital lacrimal glands of rats. Tissue Cell 14: 735-749
Samson MT, Small-Howard A, Shimoda LM, Koblan-Huberson M, Stokes AJ, Turner H (2003) Differential roles of CB1 and CB2 cannabinoid receptors in mast cells. J Immunol 170: 4953-4962
San Martin B, Bate M (2001) Hindgut visceral mesoderm requires an ectodermal template for normal development in Drosophila. Development 128: 233-242
Sanchez C, de Ceballos ML, del Pulgar TG, Rueda D, Corbacho C, Velasco G, Galve-Roperh I, Huffman JW, Ramon y Cajal S, Guzman M (2001) Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 61: 5784-5789
Sanchez C, Galve-Roperh I, Rueda D, Guzman M (1998) Involvement of sphingomyelin hydrolysis and the mitogen-activated protein kinase cascade in the Delta9-tetrahydrocannabinol-induced stimulation of glucose metabolism in primary astrocytes. Mol Pharmacol 54: 834-843
Sanchez C, Rueda D, Segui B, Galve-Roperh I, Levade T, Guzman M (2001) The CB(1) cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein fan. Mol Pharmacol 59: 955-959
Sanchez C, Velasco G, Guzman M (1997) Delta9-tetrahydrocannabinol stimulates glucose utilization in C6 glioma cells. Brain Res 767: 64-71
Sanchez C, Velasco G, Guzman M (1997) Metabolic stimulation of mouse spleen lymphocytes by low doses of delta9-tetrahydrocannabinol. Life Sci 60: 1709-1717
Sanchez MG, Ruiz-Llorente L, Sanchez AM, Diaz-Laviada I (2003) Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cell Signal 15: 851-859
Sanchez MG, Sanchez AM, Ruiz-Llorente L, Diaz-Laviada I (2003) Enhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cells. FEBS Lett 555: 561-566
Sanchis-Segura C, Cline BH, Marsicano G, Lutz B, Spanagel R (2004) Reduced sensitivity to reward in CB1 knockout mice. Psychopharmacology (Berl)
Sancho R, Calzado MA, Di Marzo V, Appendino G, Munoz E (2003) Anandamide inhibits nuclear factor-kappaB activation through a cannabinoid receptor-independent pathway. Mol Pharmacol 63: 429-438
Sancho R, de la Vega L, Appendino G, Di Marzo V, Macho A, Munoz E (2003) The CB1/VR1 agonist arvanil induces apoptosis through an FADD/caspase-8-dependent pathway. Br J Pharmacol 140: 1035-1044
Sancho R, Macho A, de La Vega L, Calzado MA, Fiebich BL, Appendino G, Munoz E (2004) Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappaB, NFAT, and activator protein 1 signaling pathways. J Immunol 172: 2341-2351
Sandilands AJ, O'Shaughnessy KM, Brown MJ (2003) Greater inotropic and cyclic AMP responses evoked by noradrenaline through Arg389 beta 1-adrenoceptors versus Gly389 beta 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138: 386-392
Sanghi S, Kumar R, Lumsden A, Dickinson D, Klepeis V, Trinkaus-Randall V, Frierson HF, Jr., Laurie GW (2001) cDNA and genomic cloning of lacritin, a novel secretion enhancing factor from the human lacrimal gland. J Mol Biol 310: 127-139
Sanna B, Kramer D, Genazzani AA (2002) The expression of the PDZ protein MALS-1/velis is regulated by calcium and calcineurin in cerebellar granule cells. J Biol Chem 277: 49585-49590
Santucci V, Storme JJ, Soubrie P, Le Fur G (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 58: PL103-110
Sanudo-Pena MC, Strangman NM, Mackie K, Walker JM, Tsou K (1999) CB1 receptor localization in rat spinal cord and roots, dorsal root ganglion, and peripheral nerve. Zhongguo Yao Li Xue Bao 20: 1115-1120
Sanudo-Pena MC, Tsou K, Romero J, Mackie K, Walker JM (2000) Role of the superior colliculus in the motor effects of cannabinoids and dopamine. Brain Res 853: 207-214
Sanz P, Moreno E, Blasco R, Repetto M (1990) Study of delayed neurotoxicity caused by fatty acid anilides in hens. Vet Hum Toxicol 32: 422-427
Saraiva M, Alcami A (2001) CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J Virol 75: 226-233
Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hahiguchi T, Kracht M, Kitajima I, Maruyama I (2003) ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death. J Neurochem 85: 50-61
Sarker KP, Maruyama I (2003) Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts. Cell Mol Life Sci 60: 1200-1208
Sarker KP, Obara S, Nakata M, Kitajima I, Maruyama I (2000) Anandamide induces apoptosis of PC-12 cells: involvement of superoxide and caspase-3. FEBS Lett 472: 39-44
Sasaki K, Burrows M (2003) Proprioceptors monitoring forces in a locust hind leg during kicking form negative feedback loops with flexor tibiae motor neurons. J Exp Biol 206: 759-769
Sasaki T, Chang MC (1997) N-arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes. Life Sci 61: 1803-1810
Sasaki T, Gallacher DV (1990) Extracellular ATP activates receptor-operated cation channels in mouse lacrimal acinar cells to promote calcium influx in the absence of phosphoinositide metabolism. FEBS Lett 264: 130-134
Sasaki T, Gallacher DV (1992) The ATP-induced inward current in mouse lacrimal acinar cells is potentiated by isoprenaline and GTP. J Physiol 447: 103-118
Sassoe-Pognetto M, Wassle H (1997) Synaptogenesis in the rat retina: subcellular localization of glycine receptors, GABA(A) receptors, and the anchoring protein gephyrin. J Comp Neurol 381: 158-174
Sato T, Shoji H, Koga N (2003) Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience. Therap Apher Dial 7: 252-258
Satoh T, Nakatsuka D, Watanabe Y, Nagata I, Kikuchi H, Namura S (2000) Neuroprotection by MAPK/ERK kinase inhibition with U0126 against oxidative stress in a mouse neuronal cell line and rat primary cultured cortical neurons. Neurosci Lett 288: 163-166
Satoh Y, Sano K, Habara Y, Kanno T (1997) Effects of carbachol and catecholamines on ultrastructure and intracellular calcium-ion dynamics of acinar and myoepithelial cells of lacrimal glands. Cell Tissue Res 289: 473-485
Savage DB, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A, Harding AH, Ihrke G, Rajanayagam O, Soos MA, George S, Berger D, Thomas EL, Bell JD, Meeran K, Ross RJ, Vidal-Puig A, Wareham NJ, O'Rahilly S, Chatterjee VK, Schafer AJ (2002) Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 31: 379-384
Savidge J, Davis C, Shah K, Colley S, Phillips E, Ranasinghe S, Winter J, Kotsonis P, Rang H, McIntyre P (2002) Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology 43: 450-456
Savinainen JR, Jarvinen T, Laine K, Laitinen JT (2001) Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes. Br J Pharmacol 134: 664-672
Savinainen JR, Saario SM, Niemi R, Jarvinen T, Laitinen JT (2003) An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors. Br J Pharmacol 140: 1451-1459
Sawada M, Alkayed NJ, Goto S, Crain BJ, Traystman RJ, Shaivitz A, Nelson RJ, Hurn PD (2000) Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse. J Cereb Blood Flow Metab 20: 112-118
Scatton B, Sanger DJ (2000) Pharmacological and molecular targets in the search for novel antipsychotics. Behav Pharmacol 11: 243-256
Schabitz WR, Giuffrida A, Berger C, Aschoff A, Schwaninger M, Schwab S, Piomelli D (2002) Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study. Stroke 33: 2112-2114
Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE (1997) Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol 142: 278-287
Schelb V, Gobel I, Khairallah L, Zhou H, Cox SL, Trendelenburg AU, Hein L, Starke K (2001) Postnatal development of presynaptic receptors that modulate noradrenaline release in mice. Naunyn Schmiedebergs Arch Pharmacol 364: 359-371
Schelegle ES (2003) Functional morphology and physiology of slowly adapting pulmonary stretch receptors. Anat Rec 270A: 11-16
Schiffmann D, Gramorski A, Gross GW (In Press) Acute neurotoxicity of trimethyl tin chloride. J Neurotoxicology
Schiffmann DA, White JH, Cooper A, Nutley MA, Harding SE, Jumel K, Solari R, Ray KP, Gay NJ (1999) Formation and biochemical characterization of tube/pelle death domain complexes: critical regulators of postreceptor signaling by the Drosophila toll receptor. Biochemistry 38: 11722-11733
Schiffrin EL (2001) A critical review of the role of endothelial factors in the pathogenesis of hypertension. J Cardiovasc Pharmacol 38 Suppl 2: S3-6
Schindler M, Harris CA, Hayes B, Papotti M, Humphrey PP (2001) Immunohistochemical localization of adenosine A1 receptors in human brain regions. Neurosci Lett 297: 211-215
Schindler M, Holloway S, Hathway G, Woolf CJ, Humphrey PP, Emson PC (1998) Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res 798: 25-35
Schindler M, Humphrey PP (1999) Differential distribution of somatostatin sst2 receptor splice variants in rat gastric mucosa. Cell Tissue Res 297: 163-168
Schlicker E, Gothert M (1998) Interactions between the presynaptic alpha2-autoreceptor and presynaptic inhibitory heteroreceptors on noradrenergic neurones. Brain Res Bull 47: 129-132
Schlicker E, Kathmann M (2001) Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 22: 565-572
Schlicker E, Redmer A, Werner A, Kathmann M (2003) Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release. Br J Pharmacol 140: 323-328
Schlicker E, Timm J, Gothert M (1996) Cannabinoid receptor-mediated inhibition of dopamine release in the retina. Naunyn Schmiedebergs Arch Pharmacol 354: 791-795
Schlicker E, Timm J, Zentner J, Gothert M (1997) Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn Schmiedebergs Arch Pharmacol 356: 583-589
Schlitzer M, Bohm M, Sattler I, Dahse HM (2000) Design, synthesis and early structure-activity relationship of farnesyltransferase inhibitors which mimic both the peptidic and the prenylic substrate. Bioorg Med Chem 8: 1991-2006
Schmetzer S, Greenidge P, Kovar KA, Schulze-Alexandru M, Folkers G (1997) Structure-activity relationships of cannabinoids: a joint CoMFA and pseudoreceptor modelling study. J Comput Aided Mol Des 11: 278-292
Schmid HH (2000) Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? Chem Phys Lipids 108: 71-87
Schmid HH, Berdyshev EV (2002) Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides: metabolism and function. Prostaglandins Leukot Essent Fatty Acids 66: 363-376
Schmid HH, Schmid PC, Berdyshev EV (2002) Cell signaling by endocannabinoids and their congeners: questions of selectivity and other challenges. Chem Phys Lipids 121: 111-134
Schmid HH, Schmid PC, Natarajan V (1990) N-acylated glycerophospholipids and their derivatives. Prog Lipid Res 29: 1-43
Schmid HH, Schmid PC, Natarajan V (1996) The N-acylation-phosphodiesterase pathway and cell signalling. Chem Phys Lipids 80: 133-142
Schmid K, Niederhoffer N, Szabo B (2003) Analysis of the respiratory effects of cannabinoids in rats. Naunyn Schmiedebergs Arch Pharmacol 368: 301-308
Schmid PC, Krebsbach RJ, Perry SR, Dettmer TM, Maasson JL, Schmid HH (1995) Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FEBS Lett 375: 117-120
Schmid PC, Kuwae T, Krebsbach RJ, Schmid HH (1997) Anandamide and other N-acylethanolamines in mouse peritoneal macrophages. Chem Phys Lipids 87: 103-110
Schmid PC, Natarajan V, Weis BK, Schmid HH (1986) Hydrolysis of N-acylated glycerophospholipids by phospholipases A2 and D: a method of identification and analysis. Chem Phys Lipids 41: 195-207
Schmid PC, Paria BC, Krebsbach RJ, Schmid HH, Dey SK (1997) Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation. Proc Natl Acad Sci U S A 94: 4188-4192
Schmid PC, Reddy PV, Natarajan V, Schmid HH (1983) Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type. J Biol Chem 258: 9302-9306
Schmid PC, Schmid HH (1987) N-Acylation of ethanolamine phospholipids by acyl transfer does not involve hydrolysis. Biochim Biophys Acta 922: 398-400
Schmid PC, Schwartz KD, Smith CN, Krebsbach RJ, Berdyshev EV, Schmid HH (2000) A sensitive endocannabinoid assay. The simultaneous analysis of N-acylethanolamines and 2-monoacylglycerols. Chem Phys Lipids 104: 185-191
Schmid PC, Schwindenhammer D, Krebsbach RJ, Schmid HH (1998) Alternative pathways of anandamide biosynthesis in rat testes. Chem Phys Lipids 92: 27-35
Schmid PC, Wold LE, Krebsbach RJ, Berdyshev EV, Schmid HH (2002) Anandamide and other N-acylethanolamines in human tumors. Lipids 37: 907-912
Schmid PC, Zuzarte-Augustin ML, Schmid HH (1985) Properties of rat liver N-acylethanolamine amidohydrolase. J Biol Chem 260: 14145-14149
Schmidt LG, Samochowiec J, Finckh U, Fiszer-Piosik E, Horodnicki J, Wendel B, Rommelspacher H, Hoehe MR (2002) Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 65: 221-224
Schneider U, Leweke FM, Mueller-Vahl KR, Emrich HM (1998) Cannabinoid/anandamide system and schizophrenia: is there evidence for association? Pharmacopsychiatry 31 Suppl 2: 110-113
Schneider U, Muller-Vahl KR, Stuhrmann M, Gadzicki D, Heller D, Seifert J, Emrich HM (2000) [In Process Citation]. Fortschr Neurol Psychiatr 68: 433-438
Schoepp DD, Jane DE, Monn JA (1999) Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology 38: 1431-1476
Schreiber V (1994) [New findings on endogenous drug receptor ligands]. Cas Lek Cesk 133: 137-139
Schuel H, Burkman LJ, Lippes J, Crickard K, Forester E, Piomelli D, Giuffrida A (2002) N-Acylethanolamines in human reproductive fluids. Chem Phys Lipids 121: 211-227
Schuel H, Burkman LJ, Lippes J, Crickard K, Mahony MC, Giuffrida A, Picone RP, Makriyannis A (2002) Evidence that anandamide-signaling regulates human sperm functions required for fertilization. Mol Reprod Dev 63: 376-387
Schuel H, Burkman LJ, Lippes J, Picone RP, Makriyannis A, Mahony MC, Giuffrida A, Piomelli D (2000) An endocannabinoid-signal system regulates human sperm. Molecular Biology of the Cell 11
Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S (1994) Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proc Natl Acad Sci U S A 91: 7678-7682
Schuldt AJ, Brand AH (1999) Mastermind acts downstream of notch to specify neuronal cell fates in the Drosophila central nervous system. Dev Biol 205: 287-295
Schulz I, Streb H, Bayerdorffer E, Thevenod F (1985) Stimulus-secretion coupling in exocrine glands: the role of inositol-1,4,5-trisphosphate, calcium and cAMP. Curr Eye Res 4: 467-473
Schuster J, Ates M, Brune K, Guhring H (2002) The cannabinoids R(-)-7-hydroxy-delta-6-tetra-hydrocannabinol-dimethylheptyl (HU-210), 2-O-arachidonoylglycerylether (HU-310) and arachidonyl-2-chloroethylamide (ACEA) increase isoflurane provoked sleep duration by activation of cannabinoids 1 (CB1)-receptors in mice. Neurosci Lett 326: 196-200
Schwabe JW, Teichmann SA (2004) Nuclear receptors: the evolution of diversity. Sci STKE 2004: pe4
Schwartz AD, Whitacre CL, Wilson DF (1999) Do ryanodine receptors regulate transmitter release at the neuromuscular junction of rat? Neurosci Lett 274: 163-166
Schwarz H, Blanco FJ, Lotz M (1994) Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55: 107-115
Schweitzer P (2000) Cannabinoids decrease the K(+) M-current in hippocampal CA1 neurons. J Neurosci 20: 51-58
Schweitzer P, Siggins GR, Madamba SG (1999) Cannabinoid modulation of neuronal activity in adult rat hippocampus. Adv Exp Med Biol 469: 547-552
Schwiening CJ, Willoughby D (2002) Depolarization-induced pH microdomains and their relationship to calcium transients in isolated snail neurones. J Physiol 538: 371-382
Scorticati C, Mohn C, De Laurentiis A, Vissio P, Fernandez Solari J, Seilicovich A, McCann SM, Rettori V (2003) The effect of anandamide on prolactin secretion is modulated by estrogen. Proc Natl Acad Sci U S A 100: 2134-2139
Seagard JL, Dean C, Patel S, Rademacher DJ, Hopp FA, Schmeling WT, Hillard CJ (2004) Anandamide content and interaction of endocannabinoid/GABA modulatory effects in the NTS on baroreflex-evoked sympathoinhibition. Am J Physiol Heart Circ Physiol 286: H992-1000
Seaman MN (2004) Cargo-selective endosomal sorting for retrieval to the Golgi requires retromer. J Cell Biol 165: 111-122
Segall Y, Quistad GB, Nomura DK, Casida JE (2003) Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors. Bioorg Med Chem Lett 13: 3301-3303
Segall Y, Quistad GB, Sparks SE, Nomura DK, Casida JE (2003) Toxicological and structural features of organophosphorus and organosulfur cannabinoid CB1 receptor ligands. Toxicol Sci 76: 131-137
Segovia G, Mora F, Crossman AR, Brotchie JM (2003) Effects of CB1 cannabinoid receptor modulating compounds on the hyperkinesia induced by high-dose levodopa in the reserpine-treated rat model of Parkinson's disease. Mov Disord 18: 138-149
Seidel K, Hamza M, Ates M, Guhring H (2003) Flurbiprofen inhibits capsaicin induced calcitonin gene related peptide release from rat spinal cord via an endocannabinoid dependent mechanism. Neurosci Lett 338: 99-102
Self DW (1999) Anandamide: a candidate neurotransmitter heads for the big leagues. Nat Neurosci 2: 303-304
Selkoe DJ, Abraham CR, Podlisny MB, Duffy LK (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J Neurochem 46: 1820-1834
Sellers LA (1999) Prolonged activation of extracellular signal-regulated kinase by a protein kinase C-dependent and N17Ras-insensitive mechanism mediates the proliferative response of G(i/o)-coupled somatostatin sst(4) receptors. J Biol Chem 274: 24280-24288
Sellers LA, Alderton F, Carruthers AM, Schindler M, Humphrey PP (2000) Receptor isoforms mediate opposing proliferative effects through gbetagamma-activated p38 or Akt pathways. Mol Cell Biol 20: 5974-5985
Sellers LA, Feniuk W, Humphrey PP, Lauder H (1999) Activated G protein-coupled receptor induces tyrosine phosphorylation of STAT3 and agonist-selective serine phosphorylation via sustained stimulation of mitogen-activated protein kinase. Resultant effects on cell proliferation. J Biol Chem 274: 16423-16430
Sellers LA, Simon J, Lundahl TS, Cousens DJ, Humphrey PP, Barnard EA (2001) Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J Biol Chem 276: 16379-16390
Selley DE, Rorrer WK, Breivogel CS, Zimmer AM, Zimmer A, Martin BR, Sim-Selley LJ (2001) Agonist efficacy and receptor efficiency in heterozygous CB1 knockout mice: relationship of reduced CB1 receptor density to G-protein activation. J Neurochem 77: 1048-1057
Selmer I, Schindler M, Allen JP, Humphrey PP, Emson PC (2000) Advances in understanding neuronal somatostatin receptors. Regul Pept 90: 1-18
Selmer IS, Schindler M, Humphrey PP, Emson PC (2000) Immunohistochemical localization of the somatostatin sst(4) receptor in rat brain. Neuroscience 98: 523-533
Selmer IS, Schindler M, Humphrey PP, Waldvogel HJ, Faull RL, Emson PC (2000) First localisation of somatostatin sst(4) receptor protein in selected human brain areas: an immunohistochemical study. Brain Res Mol Brain Res 82: 114-125
Seltzman HH, Fleming DN, Thomas BF, Gilliam AF, McCallion DS, Pertwee RG, Compton DR, Martin BR (1997) Synthesis and pharmacological comparison of dimethylheptyl and pentyl analogs of anandamide. J Med Chem 40: 3626-3634
Semyanov A, Kullmann DM (2000) Modulation of GABAergic signaling among interneurons by metabotropic glutamate receptors. Neuron 25: 663-672
Senior K (2001) Endogenously produced cannabinoids and liver cirrhosis. Lancet 358: 42
Sepe N, De Petrocellis L, Montanaro F, Cimino G, Di Marzo V (1998) Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs. Possible implications for mollusc physiology and sea food industry. Biochim Biophys Acta 1389: 101-111
Setalo G, Jr., Singh M, Guan X, Toran-Allerand CD (2002) Estradiol-induced phosphorylation of ERK1/2 in explants of the mouse cerebral cortex: the roles of heat shock protein 90 (Hsp90) and MEK2. J Neurobiol 50: 1-12
Setoguchi H, Nishimura J, Hirano K, Takahashi S, Kanaide H (2001) Leukotriene C(4) enhances the contraction of porcine tracheal smooth muscle through the activation of Y-27632, a rho kinase inhibitor, sensitive pathway. Br J Pharmacol 132: 111-118
Seutin V (2003) [Effects of nicotine and cannabinoids on the central nervous system]. Rev Med Liege 58: 19-21
Sewter C, Blows F, Considine R, Vidal-Puig A, O'Rahilly S (2002) Differential effects of adiposity on peroxisomal proliferator-activated receptor gamma1 and gamma2 messenger ribonucleic acid expression in human adipocytes. J Clin Endocrinol Metab 87: 4203-4207
Sewter CP, Digby JE, Blows F, Prins J, O'Rahilly S (1999) Regulation of tumour necrosis factor-alpha release from human adipose tissue in vitro. J Endocrinol 163: 33-38
Shah V (2001) Cellular and molecular basis of portal hypertension. Clin Liver Dis 5: 629-644
Shah YB, Prior MJ, Dixon AL, Morris PG, Marsden CA (2004) Detection of cannabinoid agonist evoked increase in BOLD contrast in rats using functional magnetic resonance imaging. Neuropharmacology 46: 379-387
Shakir KM, Simpkins CO, Gartner SL, Sobel DO, Williams TJ (1989) Phospholipase C activity in human polymorphonuclear leukocytes: partial characterization and effect of indomethacin. Enzyme 42: 197-208
Shapira M, Gafni M, Sarne Y (2003) Long-term interactions between opioid and cannabinoid agonists at the cellular level: cross-desensitization and downregulation. Brain Res 960: 190-200
Shapira M, Vogel Z, Sarne Y (2000) Opioid and cannabinoid receptors share a common pool of GTP-binding proteins in cotransfected cells, but not in cells which endogenously coexpress the receptors. Cell Mol Neurobiol 20: 291-304
Sharkey AM, King A, Clark DE, Burrows TD, Jokhi PP, Charnock-Jones DS, Loke YW, Smith SK (1999) Localization of leukemia inhibitory factor and its receptor in human placenta throughout pregnancy. Biol Reprod 60: 355-364
Sharma C, Smith T, Li S, Schroepfer GJ, Jr., Needleman DH (2000) Inhibition of Ca2+ release channel (ryanodine receptor) activity by sphingolipid bases: mechanism of action. Chem Phys Lipids 104: 1-11
Sharma S, Sharma SC (1997) An update on eicosanoids and inhibitors of cyclooxygenase enzyme systems. Indian J Exp Biol 35: 1025-1031
Shearin S, Bukoski RD (2002) Blockade of anandamide-induced relaxation and NO donor activity by ammonium paratungstate. FASEB Journal 16
Shearman LP, Rosko KM, Fleischer R, Wang J, Xu S, Tong XS, Rocha BA (2003) Antidepressant-like and anorectic effects of the cannabinoid CB1 receptor inverse agonist AM251 in mice. Behav Pharmacol 14: 573-582
Shen M, Piser TM, Seybold VS, Thayer SA (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16: 4322-4334
Shen M, Thayer SA (1998) The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons. Brain Res 783: 77-84
Shen M, Thayer SA (1998) Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity. Mol Pharmacol 54: 459-462
Shen M, Thayer SA (1999) Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture. Mol Pharmacol 55: 8-13
Sheng M, Wyszynski M (1997) Ion channel targeting in neurons. Bioessays 19: 847-853
Sherwin JR, Smith SK, Wilson A, Sharkey AM (2002) Soluble gp130 is up-regulated in the implantation window and shows altered secretion in patients with primary unexplained infertility. J Clin Endocrinol Metab 87: 3953-3960
Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R (1997) Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J Med Chem 40: 659-667
Shewan D, Dwivedy A, Anderson R, Holt CE (2002) Age-related changes underlie switch in netrin-1 responsiveness as growth cones advance along visual pathway. Nat Neurosci 5: 955-962
Shi C, Szczesniak A, Mao L, Jollimore C, Coca-Prados M, Hung O, Kelly ME (2003) A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway. Br J Pharmacol 139: 475-486
Shi J, Bui JD, Yang SH, He Z, Lucas TH, Buckley DL, Blackband SJ, King MA, Day AL, Simpkins JW (2001) Estrogens decrease reperfusion-associated cortical ischemic damage: an MRI analysis in a transient focal ischemia model. Stroke 32: 987-992
Shi Y, Agematsu K, Ochs HD, Sugane K (2003) Functional analysis of human memory B-cell subpopulations: IgD+CD27+ B cells are crucial in secondary immune response by producing high affinity IgM. Clin Immunol 108: 128-137
Shim JY, Collantes ER, Welsh WJ, Subramaniam B, Howlett AC, Eissenstat MA, Ward SJ (1998) Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis. J Med Chem 41: 4521-4532
Shim JY, Welsh WJ, Cartier E, Edwards JL, Howlett AC (2002) Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor. J Med Chem 45: 1447-1459
Shim JY, Welsh WJ, Howlett AC (2003) Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction. Biopolymers 71: 169-189
Shimasue K, Urushidani T, Hagiwara M, Nagao T (1996) Effects of anandamide and arachidonic acid on specific binding of (+) -PN200-110, diltiazem and (-) -desmethoxyverapamil to L-type Ca2+ channel. Eur J Pharmacol 296: 347-350
Shimizu K, Gurdon JB (1999) A quantitative analysis of signal transduction from activin receptor to nucleus and its relevance to morphogen gradient interpretation. Proc Natl Acad Sci U S A 96: 6791-6796
Shimizu TS, Bray D (2002) Modelling the bacterial chemotaxis receptor complex. Novartis Found Symp 247: 162-177; discussion 177-181, 198-206, 244-152
Shimizu TS, Le Novere N, Levin MD, Beavil AJ, Sutton BJ, Bray D (2000) Molecular model of a lattice of signalling proteins involved in bacterial chemotaxis. Nat Cell Biol 2: 792-796
Shiraishi T, Imai S, Uda Y (2003) The presence of ceramidase activity in liver nuclear membrane. Biol Pharm Bull 26: 775-779
Shire D, Calandra B, Bouaboula M, Barth F, Rinaldi-Carmona M, Casellas P, Ferrara P (1999) Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528. Life Sci 65: 627-635
Shire D, Calandra B, Delpech M, Dumont X, Kaghad M, Le Fur G, Caput D, Ferrara P (1996) Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A. J Biol Chem 271: 6941-6946
Shire D, Calandra B, Rinaldi-Carmona M, Oustric D, Pessegue B, Bonnin-Cabanne O, Le Fur G, Caput D, Ferrara P (1996) Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor. Biochim Biophys Acta 1307: 132-136
Shire D, Carillon C, Kaghad M, Calandra B, Rinaldi-Carmona M, Le Fur G, Caput D, Ferrara P (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270: 3726-3731
Shirokova N, Garcia J, Rios E (1998) Local calcium release in mammalian skeletal muscle. J Physiol 512 (Pt 2): 377-384
Shivachar AC, Martin BR, Ellis EF (1996) Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Biochem Pharmacol 51: 669-676
Shoshan-Barmatz V, Zchut S (1993) The interaction of local anesthetics with the ryanodine receptor of the sarcoplasmic reticulum. J Membr Biol 133: 171-181
Showalter VM, Compton DR, Martin BR, Abood ME (1996) Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278: 989-999
Shrestha R, Chapman KD (2001) N-acylethanolamine metabolism during cotton (Gossypium hirsutum L.) seed imbibition. Plant Biology (Rockville) 2001
Shrestha R, Chapman KD (2002) Biochemical characterization of cottonseed microsomal N-acylethanolamine amidohydrolase. Plant Biology (Rockville) 2002
Shrestha R, Dixon RA, Chapman KD (2003) Molecular identification of a functional homologue of the mammalian fatty acid amide hydrolase in Arabidopsis thaliana. J Biol Chem 278: 34990-34997
Shrestha R, Noordermeer MA, van der Stelt M, Veldink GA, Chapman KD (2002) N-acylethanolamines are metabolized by lipoxygenase and amidohydrolase in competing pathways during cottonseed imbibition. Plant Physiol 130: 391-401
Shrestha R, Noordermeer MA, Van der Stelt M, Veldink GA, Chapman KD (2002) N-acylethanolamines are metabolized by lipoxygenase and amidohydrolase in competing pathways during cottonseed inhibition. Plant Physiology 130: 391-401
Siddle K, Urso B, Niesler CA, Cope DL, Molina L, Surinya KH, Soos MA (2001) Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem Soc Trans 29: 513-525
Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM (2004) Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: Differences between restricting and bingeing/purging subtypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics 125B: 126-130
Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM (2004) Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes. Am J Med Genet 125B: 126-130
Sienaert I, De Smedt H, Parys JB, Missiaen L, Vanlingen S, Sipma H, Casteels R (1996) Characterization of a cytosolic and a luminal Ca2+ binding site in the type I inositol 1,4,5-trisphosphate receptor. J Biol Chem 271: 27005-27012
Sienaert I, Missiaen L, De Smedt H, Parys JB, Sipma H, Casteels R (1997) Molecular and functional evidence for multiple Ca2+-binding domains in the type 1 inositol 1,4,5-trisphosphate receptor. J Biol Chem 272: 25899-25906
Sil'kis IG (2002) [Possible mechanism of cannabinoid-mediated modulation of signal transduction through the basal ganglia]. Ross Fiziol Zh Im I M Sechenova 88: 144-157
Siljander PR, Munnix IC, Smethurst PA, Deckmyn H, Lindhout T, Ouwehand WH, Farndale RW, Heemskerk JW (2004) Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood. Blood 103: 1333-1341
Silverdale MA, McGuire S, McInnes A, Crossman AR, Brotchie JM (2001) Striatal cannabinoid CB1 receptor mRNA expression is decreased in the reserpine-treated rat model of Parkinson's disease. Exp Neurol 169: 400-406
Sim-Selley LJ (2003) Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit Rev Neurobiol 15: 91-119
Sim JA, Skynner MJ, Herbison AE (2001) Direct regulation of postnatal GnRH neurons by the progesterone derivative allopregnanolone in the mouse. Endocrinology 142: 4448-4453
Sim JA, Skynner MJ, Herbison AE (2001) Heterogeneity in the basic membrane properties of postnatal gonadotropin-releasing hormone neurons in the mouse. J Neurosci 21: 1067-1075
Sim JA, Skynner MJ, Pape JR, Herbison AE (2000) Late postnatal reorganization of GABA(A) receptor signalling in native GnRH neurons. Eur J Neurosci 12: 3497-3504
Simiand J, Keane M, Keane PE, Soubrie P (1998) SR 141716, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset. Behav Pharmacol 9: 179-181
Simmons G, Reeves JD, Grogan CC, Vandenberghe LH, Baribaud F, Whitbeck JC, Burke E, Buchmeier MJ, Soilleux EJ, Riley JL, Doms RW, Bates P, Pohlmann S (2003) DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells. Virology 305: 115-123
Simon J, Barnard EA (2003) The P2Y nucleotide receptors in the human genome. Acta Biol Hung 54: 191-201
Simon J, Filippov AK, Goransson S, Wong YH, Frelin C, Michel AD, Brown DA, Barnard EA (2002) Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells. J Biol Chem 277: 31390-31400
Simon J, Vigne P, Eklund KM, Michel AD, Carruthers AM, Humphrey PP, Frelin C, Barnard EA (2001) Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells. Br J Pharmacol 132: 173-182
Simon SM, Aderem A (1992) Myristoylation of proteins in the yeast secretory pathway. J Biol Chem 267: 3922-3931
Simoneau, II, Hamza MS, Mata HP, Siegel EM, Vanderah TW, Porreca F, Makriyannis A, Malan TP, Jr. (2001) The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets. Anesthesiology 94: 882-887
Simonian SX, Herbison AE (2001) Differing, spatially restricted roles of ionotropic glutamate receptors in regulating the migration of gnrh neurons during embryogenesis. J Neurosci 21: 934-943
Simonian SX, Spratt DP, Herbison AE (1999) Identification and characterization of estrogen receptor alpha-containing neurons projecting to the vicinity of the gonadotropin-releasing hormone perikarya in the rostral preoptic area of the rat. J Comp Neurol 411: 346-358
Simons JW, Cox RC, Egmond MR, Verheij HM (1999) Rational design of alpha-keto triglyceride analogues as inhibitors for Staphylococcus hyicus lipase. Biochemistry 38: 6346-6351
Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL (1997) Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 87: 724-730
Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM (1999) The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19: 2455-2463
Singer CA, Rogers KL, Strickland TM, Dorsa DM (1996) Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 212: 13-16
Singh M (2001) Ovarian hormones elicit phosphorylation of Akt and extracellular-signal regulated kinase in explants of the cerebral cortex. Endocrine 14: 407-415
Singh M, Setalo G, Jr., Guan X, Warren M, Toran-Allerand CD (1999) Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J Neurosci 19: 1179-1188
Singh R, Hurst DP, Barnett-Norris J, Lynch DL, Reggio PH, Guarnieri F (2002) Activation of the cannabinoid CB1 receptor may involve a W6 48/F3 36 rotamer toggle switch. J Pept Res 60: 357-370
Sinha D, Bonner TI, Bhat NR, Matsuda LA (1998) Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies. J Neuroimmunol 82: 13-21
Siniossoglou S, Peak-Chew SY, Pelham HR (2000) Ric1p and Rgp1p form a complex that catalyses nucleotide exchange on Ypt6p. Embo J 19: 4885-4894
Siniossoglou S, Pelham HR (2001) An effector of Ypt6p binds the SNARE Tlg1p and mediates selective fusion of vesicles with late Golgi membranes. Embo J 20: 5991-5998
Siniossoglou S, Pelham HR (2002) Vps51p links the VFT complex to the SNARE Tlg1p. J Biol Chem 277: 48318-48324
Sinor AD, Irvin SM, Greenberg DA (2000) Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278: 157-160
Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF (2002) A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci U S A 99: 8394-8399
Sistiaga A, Sanchez-Prieto J (2000) Protein phosphatase 2B inhibitors mimic the action of arachidonic acid and prolong the facilitation of glutamate release by group I mGlu receptors. Neuropharmacology 39: 1544-1553
Sitsapesan R, Williams AJ (1990) Mechanisms of caffeine activation of single calcium-release channels of sheep cardiac sarcoplasmic reticulum. J Physiol 423: 425-439
Siviy SM, Seifert TL (2002) Opioid and Cannabinoid Involvement in the Relative Playfulness of Juvenile Lewis and Fischer - 344 Rats. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Sjostrom PJ, Turrigiano GG, Nelson SB (2002) A Presynaptic Coincidence Detection Mechanism for Ltd in Visual Cortical Layer - 5 Neurons. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
Skaper SD, Buriani A, Dal Toso R, Petrelli L, Romanello S, Facci L, Leon A (1996) The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A 93: 3984-3989
Slipetz DM, O'Neill GP, Favreau L, Dufresne C, Gallant M, Gareau Y, Guay D, Labelle M, Metters KM (1995) Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase. Mol Pharmacol 48: 352-361
Smalley KS, Feniuk W, Sellers LA, Humphrey PP (1999) The pivotal role of phosphoinositide-3 kinase in the human somatostatin sst(4) receptor-mediated stimulation of p44/p42 mitogen-activated protein kinase and extracellular acidification. Biochem Biophys Res Commun 263: 239-243
Smalley KS, Koenig JA, Feniuk W, Humphrey PP (2001) Ligand internalization and recycling by human recombinant somatostatin type 4 (h sst(4)) receptors expressed in CHO-K1 cells. Br J Pharmacol 132: 1102-1110
Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Muir AI, Chambers JK, Randall AD, Davis JB (2000) The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 129: 227-230
Smart D, Jerman JC (2000) Anandamide: an endogenous activator of the vanilloid receptor. Trends Pharmacol Sci 21: 134
Smart D, Jerman JC, Gunthorpe MJ, Brough SJ, Ranson J, Cairns W, Hayes PD, Randall AD, Davis JB (2001) Characterisation using FLIPR of human vanilloid VR1 receptor pharmacology. Eur J Pharmacol 417: 51-58
Smart D, Jonsson KO, Vandevoorde S, Lambert DM, Fowler CJ (2002) 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism. Br J Pharmacol 136: 452-458
Smart FM, Venkitaraman AR (2000) Inhibition of interleukin 7 receptor signaling by antigen receptor assembly. J Exp Med 191: 737-742
Smethurst PA, Joutsi-Korhonen L, O'Connor MN, Wilson E, Jennings NS, Garner SF, Zhang Y, Knight CG, Dafforn TR, Buckle A, MJ IJ, De Groot PG, Watkins NA, Farndale RW, Ouwehand WH (2004) Identification of the primary collagen-binding surface on human glycoprotein VI by site-directed mutagenesis and by a blocking phage antibody. Blood 103: 903-911
Smith FL, Cichewicz D, Martin ZL, Welch SP (1998) The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Pharmacol Biochem Behav 60: 559-566
Smith FL, Fujimori K, Lowe J, Welch SP (1998) Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Pharmacol Biochem Behav 60: 183-191
Smith FM, Humphrey PP, Murrell-Lagnado RD (1999) Identification of amino acids within the P2X2 receptor C-terminus that regulate desensitization. J Physiol 520 Pt 1: 91-99
Smith JS, Coronado R, Meissner G (1985) Sarcoplasmic reticulum contains adenine nucleotide-activated calcium channels. Nature 316: 446-449
Smith JS, Coronado R, Meissner G (1986) Single channel measurements of the calcium release channel from skeletal muscle sarcoplasmic reticulum. Activation by Ca2+ and ATP and modulation by Mg2+. J Gen Physiol 88: 573-588
Smith JS, Imagawa T, Ma J, Fill M, Campbell KP, Coronado R (1988) Purified ryanodine receptor from rabbit skeletal muscle is the calcium-release channel of sarcoplasmic reticulum. J Gen Physiol 92: 1-26
Smith PA, Sellers LA, Humphrey PP (2001) Somatostatin activates two types of inwardly rectifying K+ channels in MIN-6 cells. J Physiol 532: 127-142
Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270: 219-227
Smith PF (2002) Cannabinoids in the treatment of pain and spasticity in multiple sclerosis. Curr Opin Investig Drugs 3: 859-864
Smith PJ, McQueen DS (2001) Anandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized rat. Br J Pharmacol 134: 655-663
Smith PJW, McQueen DS (2000) Anandamide-induced reflex hyperventilation is mediated by vanilloid receptors on vasosensory nerves. Journal of Physiology (Cambridge) 528P: 114P-115P
Smith PM (1992) Ins(1,3,4,5)P4 promotes sustained activation of the Ca(2+(-dependent Cl- current in isolated mouse lacrimal cells. Biochem J 283 (Pt 1): 27-30
Smith PM, Gallacher DV (1994) Thapsigargin-induced Ca2+ mobilization in acutely isolated mouse lacrimal acinar cells is dependent on a basal level of Ins(1,4,5)P3 and is inhibited by heparin. Biochem J 299 (Pt 1): 37-40
Smith PM, Harmer AR, Letcher AJ, Irvine RF (2000) The effect of inositol 1,3,4,5-tetrakisphosphate on inositol trisphosphate-induced Ca2+ mobilization in freshly isolated and cultured mouse lacrimal acinar cells. Biochem J 347 Pt 1: 77-82
Smith SJ, Augustine GJ (1988) Calcium ions, active zones and synaptic transmitter release. Trends Neurosci 11: 458-464
Smith SR, Terminelli C, Denhardt G (2000) Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. J Pharmacol Exp Ther 293: 136-150
Smith VP, Alcami A (2000) Expression of secreted cytokine and chemokine inhibitors by ectromelia virus. J Virol 74: 8460-8471
Smith VP, Alcami A (2002) Inhibition of interferons by ectromelia virus. J Virol 76: 1124-1134
Soderstrom K, Johnson F (2000) CB1 cannabinoid receptor expression in brain regions associated with zebra finch song control. Brain Res 857: 151-157
Soderstrom K, Johnson F (2001) Zebra finch CB1 cannabinoid receptor: pharmacology and in vivo and in vitro effects of activation. J Pharmacol Exp Ther 297: 189-197
Soderstrom K, Leid M, Moore FL, Murray TF (2000) Behaviroal, pharmacological, and molecular characterization of an amphibian cannabinoid receptor. J Neurochem 75: 413-423
Soderstrom K, Murray TF, Yoo HD, Ketchum S, Milligan K, Gerwick W, Ortega MJ, Salva J (1997) Discovery of novel cannabinoid receptor ligands from diverse marine organisms. Adv Exp Med Biol 433: 73-77
Soilleux EJ (2003) DC-SIGN (dendritic cell-specific ICAM-grabbing non-integrin) and DC-SIGN-related (DC-SIGNR): friend or foe? Clin Sci (Lond) 104: 437-446
Sokal DM, Elmes SJ, Kendall DA, Chapman V (2003) Intraplantar injection of anandamide inhibits mechanically-evoked responses of spinal neurones via activation of CB2 receptors in anaesthetised rats. Neuropharmacology 45: 404-411
Soltesz I, Alger BE, Piomelli D, Cravatt BF (2003) Endocannabinoids in epilepsy. Epilepsia 44: 2-3
Someya A, Horie S, Murayama T (2002) Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells. Eur J Pharmacol 450: 131-139
Somlo S, Ehrlich B (2001) Human disease: calcium signaling in polycystic kidney disease. Curr Biol 11: R356-360
Somogyi R, Kolb HA (1989) Possible involvement of a G-protein in carbamylcholine-induced gap junction closure. J Protein Chem 8: 434-436
Song C, Howlett AC (1995) Rat brain cannabinoid receptors are N-linked glycosylated proteins. Life Sci 56: 1983-1989
Song ZH, Bonner TI (1996) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Mol Pharmacol 49: 891-896
Song ZH, Feng W (2002) Absence of a conserved proline and presence of a conserved tyrosine in the CB2 cannabinoid receptor are crucial for its function. FEBS Lett 531: 290-294
Song ZH, Slowey CA (2000) Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2. J Pharmacol Exp Ther 292: 136-139
Song ZH, Slowey CA, Hurst DP, Reggio PH (1999) The difference between the CB(1) and CB(2) cannabinoid receptors at position 5.46 is crucial for the selectivity of WIN55212-2 for CB(2). Mol Pharmacol 56: 834-840
Song ZH, Zhong M (2000) CB1 cannabinoid receptor-mediated cell migration. J Pharmacol Exp Ther 294: 204-209
Sonnleitner A, Conti A, Bertocchini F, Schindler H, Sorrentino V (1998) Functional properties of the ryanodine receptor type 3 (RyR3) Ca2+ release channel. Embo J 17: 2790-2798
Soria-Gomez EJ, Garcia X, Rueda-Orozco P, Guzman-Vasquez K, Prospero-Garcia O (2003) Anandamide and oleamide administration into the nucleus accumbens shell increases food intake in rats. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Sorrentino V, Barone V, Rossi D (2000) Intracellular Ca(2+) release channels in evolution. Curr Opin Genet Dev 10: 662-667
Souilhac J, Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrie P (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol Biochem Behav 51: 3-7
Souza HC, Salgado HC, Ballejo G, Salgado MC (2003) SR141716A-sensitive enhancement of ET-1 hypotensive effect by chronic NOS inhibition. Hypertension 42: 802-805
Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A (2003) Exercise activates the endocannabinoid system. Neuroreport 14: 2209-2211
Spatz M, Chen Y, Golech S, Bembry J, Mechoulam R, McCarron RM (2001) Endocannibinoid 2-arachidonoyl glycerol modulates ET-1-induced brain endothelium responses. Society for Neuroscience Abstracts 27
Spatz M, McCarron RM, Chen Y, Golech S, Mechoulam R (2003) 2 - Arachidonoyl glycerol modulation of cerebral microvascular endothelial responses to H2O2. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Speake T, Douglas IJ, Brown PD (1998) The role of calcium in the volume regulation of rat lacrimal acinar cells. J Membr Biol 164: 283-291
Speake T, Elliott AC (1998) Modulation of calcium signals by intracellular pH in isolated rat pancreatic acinar cells. J Physiol 506 (Pt 2): 415-430
Speake T, Yodozawa S, Elliott AC (1998) Modulation of calcium signalling by intracellular pH in exocrine acinar cells. Eur J Morphol 36 Suppl: 165-169
Spicuzza L, Haddad EB, Birrell M, Ling A, Clarke D, Venkatesan P, Barnes PJ, Belvisi MG (2000) Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves. Br J Pharmacol 130: 1720-1726
Spier AD, Lummis SC (2000) The role of tryptophan residues in the 5-Hydroxytryptamine(3) receptor ligand binding domain. J Biol Chem 275: 5620-5625
Spier AD, Wotherspoon G, Nayak SV, Nichols RA, Priestley JV, Lummis SC (1999) Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors. Brain Res Mol Brain Res 67: 221-230
Sprague J, Harrison C, Rowbotham DJ, Smart D, Lambert DG (2001) Temperature-dependent activation of recombinant rat vanilloid VR1 receptors expressed in HEK293 cells by capsaicin and anandamide. Eur J Pharmacol 423: 121-125
Spratt DP, Herbison AE (2001) Sexually dimorphic effects of testosterone on preoptic area calcitonin gene-related peptide mRNA expression depend upon neuron location and differential estrogen and androgen receptor activation. Endocrinology 142: 3397-3404
Stadler J, Keenan TW, Bauer G, Gerisch G (1989) The contact site A glycoprotein of Dictyostelium discoideum carries a phospholipid anchor of a novel type. Embo J 8: 371-377
Stahl SM (1998) Getting stoned without inhaling: anandamide is the brain's natural marijuana. J Clin Psychiatry 59: 566-567
Staines DM, Thomas JO (1999) A sequence with homology to human HPFH-linked enhancer elements and to a family of G-protein linked membrane receptor genes is located downstream of the chicken beta-globin locus. Gene 234: 345-352
Stamatakis EA, Hetherington MM (2003) Neuroimaging in eating disorders. Nutr Neurosci 6: 325-334
Stamatov SD, Stawinski J (2002) Novel, regioselective transformation of an oxirane system. An efficient approach to the synthesis of endocannabinoid 2-arachidonoylglycerol. Tetrahedron Letters 43: 1759-1761
Stamer WD, Golightly SF, Hosohata Y, Ryan EP, Porter AC, Varga E, Noecker RJ, Felder CC, Yamamura HI (2001) Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. Eur J Pharmacol 431: 277-286
Stanford SJ, Gitlin JM, Mitchell JA (2001) Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat. Br J Pharmacol 133: 825-832
Stanley MA (2002) Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential. Clin Exp Dermatol 27: 571-577
Stark S, Pacheco MA, Childers SR (1997) Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells. Cell Mol Neurobiol 17: 483-493
Stefano GB (1998) Autoimmunovascular regulation: morphine and anandamide and ancondamide stimulated nitric oxide release. J Neuroimmunol 83: 70-76
Stefano GB (2000) Endocannabinoid immune and vascular signaling. Acta Pharmacol Sin 21: 1071-1081
Stefano GB, Bilfinger TV, Rialas CM, Deutsch DG (2000) 2-arachidonyl-glycerol stimulates nitric oxide release from human immune and vascular tissues and invertebrate immunocytes by cannabinoid receptor 1. Pharmacol Res 42: 317-322
Stefano GB, Esch T, Cadet P, Zhu W, Mantione K, Benson H (2003) Endocannabinoids as autoregulatory signaling molecules: coupling to nitric oxide and a possible association with the relaxation response. Med Sci Monit 9: RA63-75
Stefano GB, Goumon Y, Bilfinger TV, Welters ID, Cadet P (2000) Basal nitric oxide limits immune, nervous and cardiovascular excitation: human endothelia express a mu opiate receptor. Prog Neurobiol 60: 513-530
Stefano GB, Liu Y, Goligorsky MS (1996) Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J Biol Chem 271: 19238-19242
Stefano GB, Rialas CM, Deutsch DG, Salzet M (1998) Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. Brain Res 793: 341-345
Stefano GB, Salzet B, Rialas CM, Pope M, Kustka A, Neenan K, Pryor S, Salzet M (1997) Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res 763: 63-68
Stefano GB, Salzet B, Salzet M (1997) Identification and characterization of the leech CNS cannabinoid receptor: coupling to nitric oxide release. Brain Res 753: 219-224
Stefano GB, Salzet M, Bilfinger TV (1998) Long-term exposure of human blood vessels to HIV gp120, morphine, and anandamide increases endothelial adhesion of monocytes: uncoupling of nitric oxide release. J Cardiovasc Pharmacol 31: 862-868
Stefano GB, Salzet M, Magazine HI, Bilfinger TV (1998) Antagonism of LPS and IFN-gamma induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J Cardiovasc Pharmacol 31: 813-820
Stefano GB, Salzet M, Rialas CM, Mattocks D, Fimiani C, Bilfinger TV (1998) Macrophage behavior associated with acute and chronic exposure to HIV GP120, morphine and anandamide: endothelial implications. Int J Cardiol 64 Suppl 1: S3-13
Steffens M, Engler C, Zentner J, Feuerstein TJ (2004) Cannabinoid CB1 receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex. Br J Pharmacol 141: 1193-1203
Steffens M, Feuerstein TJ (2004) Receptor-independent depression of DA and 5-HT uptake by cannabinoids in rat neocortex-involvement of Na+/K+-ATPase. Neurochemistry International 44: 529-538
Steffens M, Feuerstein TJ, van Velthoven V, Schnierle P, Knorle R (2003) Quantitative measurement of depolarization-induced anandamide release in human and rat neocortex. Naunyn Schmiedebergs Arch Pharmacol 368: 432-436
Steffens M, Klar M, Szabo B, Zentner J, Feuerstein TJ (2002) Modulation of evoked (3H)-acetylcholine release in neocortical slices of humans and mice through CB1 receptors: Evidence for an endogenous tone in humans. Naunyn-Schmiedeberg's Archives of Pharmacology 365
Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ (2003) Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex. Neuroscience 120: 455-465
Stein EA, Fuller SA, Edgemond WS, Campbell WB (1996) Physiological and behavioural effects of the endogenous cannabinoid, arachidonylethanolamide (anandamide), in the rat. Br J Pharmacol 119: 107-114
Stein EA, Fuller SA, Edgemond WS, Campbell WB (1998) Selective effects of the endogenous cannabinoid arachidonylethanolamide (anandamide) on regional cerebral blood flow in the rat. Neuropsychopharmacology 19: 481-491
Steiner H, Bonner TI, Zimmer AM, Kitai ST, Zimmer A (1999) Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice. Proc Natl Acad Sci U S A 96: 5786-5790
Stella N
Stella N, Piomelli D (2001) Receptor-dependent formation of endogenous cannabinoids in cortical neurons. Eur J Pharmacol 425: 189-196
Stella N, Schweitzer P, Piomelli D (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778
Stengel PW, Rippy MK, Cockerham SL, Devane WA, Silbaugh SA (1998) Pulmonary actions of anandamide, an endogenous cannabinoid receptor agonist, in guinea pigs. Eur J Pharmacol 355: 57-66
Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter GF, Holmes AB, Gaffney PR, Reese CB, McCormick F, Tempst P, Coadwell J, Hawkins PT (1998) Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science 279: 710-714
Stephens LR, Anderson KE, Hawkins PT (2001) Src family kinases mediate receptor-stimulated, phosphoinositide 3-kinase-dependent, tyrosine phosphorylation of dual adaptor for phosphotyrosine and 3-phosphoinositides-1 in endothelial and B cell lines. J Biol Chem 276: 42767-42773
Stevens J, Jones RC, Bordoli RS, Trowsdale J, Gaskell SJ, Butcher GW, Joly E (2000) Peptide specificity of RT1-A1(c), an inhibitory rat major histocompatibility complex class I natural killer cell ligand. J Biol Chem 275: 29217-29224
Stoffel W, Kruger E, Melzner I (1980) Studies on the biosynthesis of ceramide. Does the reversed ceramidase reaction yield ceramides? Hoppe Seylers Z Physiol Chem 361: 773-779
Stoit AR, Lange JH, Hartog AP, Ronken E, Tipker K, Stuivenberg HH, Dijksman JA, Wals HC, Kruse CG (2002) Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists. Chem Pharm Bull (Tokyo) 50: 1109-1113
Stoops JK, Wakil SJ (1981) Animal fatty acid synthetase. A novel arrangement of the beta-ketoacyl synthetase sites comprising domains of the two subunits. J Biol Chem 256: 5128-5133
Storey H, Stewart A, Vandenabeele P, Luzio JP (2002) The p55 tumour necrosis factor receptor TNFR1 contains a trans-Golgi network localization signal in the C-terminal region of its cytoplasmic tail. Biochem J 366: 15-22
Storr M, Gaffal E, Saur D, Schusdziarra V, Allescher HD (2002) Effect of cannabinoids on neural transmission in rat gastric fundus. Can J Physiol Pharmacol 80: 67-76
Storr M, Sibaev A, Marsicano G, Lutz B, Schusdziarra V, Timmermans JP, Allescher HD (2004) Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Am J Physiol Gastrointest Liver Physiol 286: G110-117
Straiker A, Stella N, Piomelli D, Mackie K, Karten HJ, Maguire G (1999) Cannabinoid CB1 receptors and ligands in vertebrate retina: localization and function of an endogenous signaling system. Proc Natl Acad Sci U S A 96: 14565-14570
Straiker A, Sullivan JM (2003) Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander. J Neurophysiol 89: 2647-2654
Straiker AJ, Borden CR, Sullivan JM (2002) G-protein alpha subunit isoforms couple differentially to receptors that mediate presynaptic inhibition at rat hippocampal synapses. J Neurosci 22: 2460-2468
Straiker AJ, Maguire G, Mackie K, Lindsey J (1999) Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Vis Sci 40: 2442-2448
Strangman NM, Patrick SL, Hohmann AG, Tsou K, Walker JM (1998) Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity. Brain Res 813: 323-328
Street VA, Bosma MM, Demas VP, Regan MR, Lin DD, Robinson LC, Agnew WS, Tempel BL (1997) The type 1 inositol 1,4,5-trisphosphate receptor gene is altered in the opisthotonos mouse. J Neurosci 17: 635-645
Striggow F, Ehrlich BE (1996) The inositol 1,4,5-trisphosphate receptor of cerebellum. Mn2+ permeability and regulation by cytosolic Mn2+. J Gen Physiol 108: 115-124
Striggow F, Ehrlich BE (1997) Regulation of intracellular calcium release channel function by arachidonic acid and leukotriene B4. Biochem Biophys Res Commun 237: 413-418
Stuart AD, Eustace HE, McKee TA, Brown TD (2002) A novel cell entry pathway for a DAF-using human enterovirus is dependent on lipid rafts. J Virol 76: 9307-9322
Stuart AD, McKee TA, Williams PA, Harley C, Shen S, Stuart DI, Brown TD, Lea SM (2002) Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection. J Virol 76: 7694-7704
Sudhof TC, Newton CL, Archer BT, 3rd, Ushkaryov YA, Mignery GA (1991) Structure of a novel InsP3 receptor. Embo J 10: 3199-3206
Sugimoto H, Yamashita S (1999) Characterization of the transacylase activity of rat liver 60-kDa lysophospholipase-transacylase. Acyl transfer from the sn-2 to the sn-1 position. Biochim Biophys Acta 1438: 264-272
Sugiura T, Kobayashi Y, Oka S, Waku K (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 66: 173-192
Sugiura T, Kodaka T, Kondo S, Nakane S, Kondo H, Waku K, Ishima Y, Watanabe K, Yamamoto I (1997) Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells. J Biochem (Tokyo) 122: 890-895
Sugiura T, Kodaka T, Kondo S, Tonegawa T, Nakane S, Kishimoto S, Yamashita A, Waku K (1996) 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 229: 58-64
Sugiura T, Kodaka T, Kondo S, Tonegawa T, Nakane S, Kishimoto S, Yamashita A, Waku K (1997) Inhibition by 2-arachidonoylglycerol, a novel type of possible neuromodulator, of the depolarization-induced increase in intracellular free calcium in neuroblastoma x glioma hybrid NG108-15 cells. Biochem Biophys Res Commun 233: 207-210
Sugiura T, Kodaka T, Nakane S, Kishimoto S, Kondo S, Waku K (1998) Detection of an endogenous cannabimimetic molecule, 2-arachidonoylglycerol, and cannabinoid CB1 receptor mRNA in human vascular cells: is 2-arachidonoylglycerol a possible vasomodulator? Biochem Biophys Res Commun 243: 838-843
Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, Ishima Y (1999) Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J Biol Chem 274: 2794-2801
Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H, Waku K (2000) Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. J Biol Chem 275: 605-612
Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89-97
Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Ishima Y, Waku K (1996) Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes. Comparison with synthesis from free arachidonic acid and ethanolamine. Eur J Biochem 240: 53-62
Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K (1996) Enzymatic synthesis of anandamide, an endogenous cannabinoid receptor ligand, through N-acylphosphatidylethanolamine pathway in testis: involvement of Ca(2+)-dependent transacylase and phosphodiesterase activities. Biochem Biophys Res Commun 218: 113-117
Sugiura T, Kondo S, Sukagawa A, Tonegawa T, Nakane S, Yamashita A, Waku K (1996) N-arachidonoylethanolamine (anandamide), an endogenous cannabinoid receptor ligand, and related lipid molecules in the nervous tissues. J Lipid Mediat Cell Signal 14: 51-56
Sugiura T, Waku K (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. Chem Phys Lipids 108: 89-106
Sugiura T, Waku K (2000) 2-arachidonoylglycerol: a possible multifunctional lipid mediator in the nervous and immune systems. Ann N Y Acad Sci 905: 344-346
Sugiura T, Waku K (2001) 2-arachidonoylglycerol: an endogenous cannabinoid receptor agonist. World Rev Nutr Diet 88: 200-206
Sugiura T, Waku K (2002) Cannabinoid receptors and their endogenous ligands. J Biochem (Tokyo) 132: 7-12
Sugiura T, Yoshinaga N, Kondo S, Waku K, Ishima Y (2000) Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem Biophys Res Commun 271: 654-658
Sugiura T, Yoshinaga N, Waku K (2001) Rapid generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in rat brain after decapitation. Neurosci Lett 297: 175-178
Suhara Y, Nakane S, Arai S, Takayama H, Waku K, Ishima Y, Sugiura T (2001) Synthesis and biological activities of novel structural analogues of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Bioorg Med Chem Lett 11: 1985-1988
Suhara Y, Takayama H, Nakane S, Miyashita T, Waku K, Sugiura T (2000) Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues. Chem Pharm Bull (Tokyo) 48: 903-907
Sulcova A, Landa L (2003) Co-administration with cannabinoid receptor antagonist AM251 attenuates behavioural sensitization to methamphetamine antiaggressive effect in mice. Behavioural Pharmacology 14: S59-S60
Sulcova E, Mechoulam R, Fride E (1998) Biphasic effects of anandamide. Pharmacol Biochem Behav 59: 347-352
Sun YX, Tsuboi K, Okamoto Y, Tonai T, Murakami M, Kudo I, Ueda N (2004) Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A 2 and lysophospholipase D. Biochem J Pt
Sundermeier T, Matthews G, Brink PR, Walcott B (2002) Calcium dependence of exocytosis in lacrimal gland acinar cells. Am J Physiol Cell Physiol 282: C360-365
Sunter D, Hewson AK, Dickson SL (2003) Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 353: 1-4
Supattapone S, Worley PF, Baraban JM, Snyder SH (1988) Solubilization, purification, and characterization of an inositol trisphosphate receptor. J Biol Chem 263: 1530-1534
Suplita RL, II, Farthing JN, Gutierrez T, Neely MH, Hohmann AG (2003) Endocannabinoids induce stress - induced analgesia through descending mechanisms. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Suplita RL, II, Nackley AG, Hohmann AG (2001) Site of action of endocannabinoid mechanisms of nonopioid stress-induced analgesia. Society for Neuroscience Abstracts 27
Surinya KH, Molina L, Soos MA, Brandt J, Kristensen C, Siddle K (2002) Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. J Biol Chem 277: 16718-16725
Suzuki K, Ando T (1972) Studies on protamines. XVI. The complete amino acid sequence of clupeine YII. J Biochem (Tokyo) 72: 1419-1432
Swamy MJ, Ramakrishnan M, Angerstein B, Marsh D (2000) Spin-label electron spin resonance studies on the mode of anchoring and vertical location of the N-acyl chain in N-acylphosphatidylethanolamines. Biochemistry 39: 12476-12484
Swatton JE, Morris SA, Cardy TJ, Taylor CW (1999) Type 3 inositol trisphosphate receptors in RINm5F cells are biphasically regulated by cytosolic Ca2+ and mediate quantal Ca2+ mobilization. Biochem J 344 Pt 1: 55-60
Swatton JE, Morris SA, Wissing F, Taylor CW (2001) Functional properties of Drosophila inositol trisphosphate receptors. Biochem J 359: 435-441
Swatton JE, Taylor CW (2002) Fast biphasic regulation of type 3 inositol trisphosphate receptors by cytosolic calcium. J Biol Chem 277: 17571-17579
Szabo B, Dorner L, Pfreundtner C, Norenberg W, Starke K (1998) Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum. Neuroscience 85: 395-403
Szabo B, Muller T, Koch H (1999) Effects of cannabinoids on dopamine release in the corpus striatum and the nucleus accumbens in vitro. J Neurochem 73: 1084-1089
Szabo B, Siemes S, Wallmichrath I (2002) Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids. Eur J Neurosci 15: 2057-2061
Szabo B, Than M, Wallmichrath I, Thorn D (2004) Analysis of the effects of cannabinoids on synaptic transmission between basket and Purkinje cells in the cerebellar cortex of the rat. J Pharmacol Exp Ther
Szallasi A (2001) Vanilloid receptor ligands: hopes and realities for the future. Drugs Aging 18: 561-573
Szallasi A (2002) Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol 118: 110-121
Szallasi A, Di Marzo V (2000) New perspectives on enigmatic vanilloid receptors. Trends Neurosci 23: 491-497
Szallasi A, Fowler CJ (2002) After a decade of intravesical vanilloid therapy: still more questions than answers. Lancet Neurol 1: 167-172
Szendrei K (2004) [A novel analgesics made from Cannabis]. Ideggyogy Sz 57: 36-40
Szoke E, Balla Z, Csernoch L, Czeh G, Szolcsanyi J (2000) Interacting effects of capsaicin and anandamide on intracellular calcium in sensory neurones. Neuroreport 11: 1949-1952
Szoke E, Czeh G, Szolcsanyi J, Seress L (2002) Neonatal anandamide treatment results in prolonged mitochondrial damage in the vanilloid receptor type 1-immunoreactive B-type neurons of the rat trigeminal ganglion. Neuroscience 115: 805-814
Szolcsanyi J (2000) Anandamide and the question of its functional role for activation of capsaicin receptors. Trends Pharmacol Sci 21: 203-204
Szostak VA, Feldman DE (2003) Spike timing dependent long term depression in l2/3 of rat barrel cortex requires CB1 receptors but not synaptically driven NMDA receptor currents. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Szuts D, Bienz M (2000) An autoregulatory function of Dfos during Drosophila endoderm induction. Mech Dev 98: 71-76
Szuts D, Eresh S, Bienz M (1998) Functional intertwining of Dpp and EGFR signaling during Drosophila endoderm induction. Genes Dev 12: 2022-2035